Screener
Capricor Therapeutics CAPR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| Marketable securities | 173,188,430 | 30,281,603 | |
| Receivables | — | 59,167 | |
| Prepaid expenses and other current assets | 4,478,895 | 4,751,674 | |
| TOTAL CURRENT ASSETS | 283,088,809 | 322,939,756 | |
| PROPERTY AND EQUIPMENT, net | 28,502,617 | 18,312,238 | |
| OTHER ASSETS | |||
| Lease right-of-use assets, net | 13,158,500 | 13,537,820 | |
| Other assets | 1,533,591 | 1,159,480 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's total current assets?
- Capricor Therapeutics (CAPR) reported total current assets of $283.09M in Q1 2026.
- How has Capricor Therapeutics's total current assets changed year-over-year?
- Capricor Therapeutics's total current assets increased by 93.6% year-over-year, from $146.25M to $283.09M.
- What is the long-term trend for Capricor Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total current assets has grown at a 57.2% compound annual growth rate (CAGR), from $33.68M to $322.94M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Capricor Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude